In patients with Huntington’s disease postprandial ghrelin expression is suppressed and worsens as the locomotor impairment advances, so that the dynamics of the plasma levels of ghrelin could be used for assessment of disease’s progression (Aziz et al., 2010; Weir et al., 2011). This evidence concerns the gene GHRL and juvenile Huntington disease.